WallStreetZenWallStreetZen

NASDAQ: EXEL
Exelixis Inc Earnings & Revenue

EXEL past earnings growth

How has EXEL's earnings growth performed historically?
Company
33.33%
Industry
23.59%
Market
126.85%
EXEL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
EXEL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
EXEL's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

EXEL past revenue growth

How has EXEL's revenue growth performed historically?
Company
10.98%
Industry
89.98%
Market
18.88%
EXEL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EXEL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EXEL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EXEL earnings and revenue history

Current Revenue
$1.8B
Current Earnings
$205.1M
Current Profit Margin
11.1%

EXEL Return on Equity

Current Company
8.9%
Current Industry
16.8%
Current Market
28.2%
EXEL's Return on Equity (8.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EXEL announces earnings.

EXEL Return on Assets

Current Company
6.9%
Current Industry
3.2%
EXEL is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EXEL Return on Capital Employed

Current Company
10.64%
Current Industry
-42.4%
EXEL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EXEL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EXEL$1.85B$312.76M$205.05M+16.63%-21.67%
SMMT$0.00-$114.32M-$116.03M-100.00%N/A
JAZZ$3.84B$1.16B$330.79M+14.48%-8.51%
HALO$862.99M$495.45M$318.80M+37.13%+101.37%
IONS$776.62M-$254.76M-$384.77M+0.63%N/A

EXEL earnings dates

Next earnings date
Jul 30, 2024

Exelixis Earnings & Revenue FAQ

What were EXEL's earnings last quarter?

On Invalid Date, Exelixis (NASDAQ: EXEL) reported Q1 2024 earnings per share (EPS) of $0.12, up 0% year over year. Total Exelixis earnings for the quarter were $37.32 million. In the same quarter last year, Exelixis's earnings per share (EPS) was $0.12.

If you're new to stock investing, here's how to buy Exelixis stock.

What was EXEL's earnings growth in the past year?

As of Q3 2024, Exelixis's earnings has grown 33.33% year over year. This is 9.74 percentage points higher than the US Biotechnology industry earnings growth rate of 23.59%. Exelixis's earnings in the past year totalled $205.05 million.

What is EXEL's earnings date?

Exelixis's earnings date is Invalid Date. Add EXEL to your watchlist to be reminded of EXEL's next earnings announcement.

What was EXEL's revenue last quarter?

On Invalid Date, Exelixis (NASDAQ: EXEL) reported Q1 2024 revenue of $425.23 million up 4.02% year over year. In the same quarter last year, Exelixis's revenue was $408.79 million.

What was EXEL's revenue growth in the past year?

As of Q3 2024, Exelixis's revenue has grown 10.98% year over year. This is 78.99 percentage points lower than the US Biotechnology industry revenue growth rate of 89.98%. Exelixis's revenue in the past year totalled $1.85 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.